A Single-center, Randomized, Active-controlled, Parallel-group, Open-label, Phase I Study to Evaluate Safety and Immunogenicity of Single Injection of LBVD or Eupenta Co-administered With Imovax Polio in Healthy Adults
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs DTP-HepB-IPV-Hib vaccine LG Chem (Primary) ; Hib-DTP-hepatitis B vaccine; Poliovirus vaccine inactivated
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions
- Sponsors LG Chem
- 24 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2017 New trial record
- 05 Jul 2017 Planned End Date changed from 13 Oct 2017 to 1 Oct 2017.